About: http://data.cimple.eu/news-article/5816722a2c0a0dd5bf93b8fc0a7e4f589a12fba6007ebbd7590318a4

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/5816722a2c0a0dd5bf93b8fc0a7e4f589a12fba6007ebbd7590318a4 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The new anti-retroviral therapy cabotegravir could be a "game changer" as a study shows it is many times more effective in preventing HIV in women as PrEP, the UNAIDS body said Monday. Injected in women every two months, cabotegravir is 89 percent more effective in preventing HIV than daily pills of PrEP, pre-exposure prophylaxis, the UNAIDS body said. "UNAIDS has long been calling for additional, acceptable and effective HIV prevention options for women, and this could be a real game-changer," its chief Winnie Byanyima said in a statement. "If donors and countries invest in rolling out access of injectable PrEP to women at higher risk of HIV, new infections could be dramatically reduced." The trial involved more than 3,200 women between 18 and 45 years old who were at higher risk of acquiring HIV, the virus that causes AIDS, in Botswana, Kenya, Malawi, South Africa, Eswatini, Uganda and Zimbabwe, UNAIDS said. It said expert monitors stopped the trial earlier than planned because there was "clear statistical evidence showing that the injectable medicine is more effective than a daily pill," the body said. It added that four women who received injections became infected with HIV, as opposed to 34 women who took the pills, with all the treatments administered in a random fashion. "The risk of HIV was ninefold lower with cabotegravir injections than with daily oral PrEP," it said. UNAIDS said the test results were important in boosting the fight against AIDS by offering women new ways to protect themselves beyond using daily pills, ensuring condoms are worn or abstaining from sex. "Like with a COVID-19 vaccine, we now must work to ensure that these life-changing injections are accessible, affordable and equitably distributed to people who choose to use them," Byanyima said. vog/lc/ach
schema:headline	UN hails new therapy to prevent HIV in women
schema:mentions	Eswatini Botswana Malawi HIV/AIDS Medication Zimbabwe Uganda HIV Kenya United Nations South Africa Virus Coronavirus disease 2019 Cabotegravir Winnie Byanyima Pre-exposure prophylaxis Vog
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-11-09 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software